Looking for the best growth stocks to buy in 2026? The Top 20 Improvers portfolio is designed as a dynamic sector ETF alternative, focusing on undervalued stocks with significant upside potential for Q1 2026 and beyond. With a Tradestie Score of 57.83/100 and a stellar Diversification Score of 90.6/100, this portfolio targets companies showing remarkable improvement in fundamentals across key industries like the technology sector (34%), healthcare stocks (16%), and consumer cyclical markets (12%). Whether you're chasing aggressive growth or diversifying your holdings, this portfolio offers a compelling mix of 20 carefully selected stocks poised to outperform in the 2026 market outlook.
The stock selection process highlights emerging and established names like Amesite Operating Co (AMST), Burlington Stores Inc (BURL), and Aptorum Group Ltd Class A (APM), each holding a significant 7.5% allocation. Other top holdings include indie Semiconductor Inc (INDI) and Armstrong World Industries Inc (AWI) at 5.4%, alongside Align Technology Inc (ALGN) and Alkermes Plc (ALKS) at 4.3%. These companies are chosen for their innovation in high-growth areas like tech stocks to buy and healthcare solutions, as well as their current valuation suggesting room for appreciation. For instance, AMTD IDEA Group (AMTD) in financial services and Vaalco Energy Inc (EGY) in energy add sector diversity with strong fundamentals for the coming years.
Tailored for the aggressive growth investor or those building a retirement portfolio, the Top 20 Improvers is ideal for anyone seeking capital appreciation over passive income. However, investors should note market risks such as volatility in the technology sector and geopolitical impacts on industrials like AWI. With sector-specific challenges in healthcare stocks like ALKS, staying informed on regulatory shifts is key to navigating this high-potential portfolio in 2026.